Vishal Verma

Mr. Vishal Verma

Sports Biosciences, Central University of Rajasthan, Ajmer, India
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2025 in Gels
Verified
Journal Article
Open access
PDF file
Vishal VermaVishal Verma
Vishal Verma
VGVishal Gill
Vishal Gill
AKAVINASH KUMAR
AVINASH KUMAR
SSShailendra Pratap Singh
Shailendra Pratap Singh
This study was aimed at providing athletes a solution to replenish the muscle glycogen re-synthesis at an optimal rate with hemp seeds as a natural protein source and Bengal gram dal and its use for the preparation of gel. The gel contains the richest source of energy, and it is an effective way to provide energy and nutrients to athletes. The gel was prepared in three variations with different hemp seed concentrations. We then analyzed the gel for pH and macronutrient composition. The sensory characteristics were analyzed for seven parameters, including appearance, taste, color, texture, aroma, consistency, and acceptability, using a hedonic scale on 25 panelists. A sensory analysis showed that sample A received an overall acceptability score of 7.16 ± 0.99 from the sensory panel. The shelf life was observed at the recommended temperature of 4 degrees Celsius, which was 12 days. The best formulation was sample B with 38 g of hemp seeds, which showed better taste, color, aroma, and acceptability and a lower average pH value (6.68 ± 1.44, 6.56 ± 1.29, 7.6 ± 1.16, 7 ± 1.26, and 5.822 ± 0.0183, respectively). Sample B contained 30.8 g of protein, 16.09 g of carbohydrates, 8.4 g of fat, and 263.16 kcal of energy per 100 g. The resulting ratio of carbohydrates to protein is optimal for use as a high-protein post-workout meal. Hence, it can be considered a post-workout supplement.

26 October 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
AKAVINASH KUMAR
AVINASH KUMAR
VGVishal Gill
Vishal Gill
Vishal VermaVishal Verma
Vishal Verma
SSShailendra Pratap Singh
Shailendra Pratap Singh
The effects of nutraceuticals β-glucan, taurine, and L-arginine under hypoxia, and their significance for athletes, remain unknown. We evaluated these compounds in vitro and tested β-glucan supplementation in athletes. H9c2 cardiomyoblasts were subjected to CoCl2-induced chemical hypoxia to assess metabolic activity, morphology, transcript profiles, and mitochondrial/glycolytic function. In an uncontrolled, single-arm pre–post trial, 50 male athletes received β-glucan-rich mushroom extract (320 mg/day) for 40 days. Body composition, complete blood count, and cardiopulmonary exercise testing were assessed pre- and post-supplementation. CoCl2 decreased MTT metabolic activity to 67.29 ± 0.87% of control. The three compounds significantly increased MTT metabolic activity (83.65–97.40%; p < 0.001 vs. positive control). Taurine, β-glucan, and L-arginine all reduced Hif1a transcript (FC = 0.44, 0.58, and 0.47, respectively; all p < 0.001 vs. positive control). Seahorse examination revealed partial preservation of mitochondrial parameters and improved glycolytic reserve, with L-arginine (120.4%) and taurine (105.1%) numerically higher than the negative control (86.0 ± 20.2%), but neither difference was statistically significant. The transcriptional alterations were compound-specific and exploratory. Athletes who supplemented with multi-mushroom extract for 40 days had higher relative VO2/kg (46.26 ± 2.33 to 53.12 ± 3.75 mL/min/kg; +14.8%; p < 0.001), absolute VO2 (3138.46 ± 313.38 to 3503.82 ± 371.73 mL/min; +11.6%; p < 0.001), and peak RQ (1.096 ± 0.048 to 1.308 ± 0.082; p < 0.001). HCT dropped (44.53 ± 2.81% to 42.10 ± 2.64%; p < 0.001), MCV increased (86.37 ± 2.20 to 89.67 ± 2.32 fL; p < 0.001), and MCHC fell (35.10 ± 0.80 to 33.78 ± 0.53 g/dL; p < 0.001). WBC levels reduced (7.53 ± 1.31 to 6.80 ± 1.02 × 103/µL; p = 0.004), neutrophils fell (61.00 ± 8.34% to 52.02 ± 5.66%; p < 0.001), lymphocytes rose (27.80 ± 3.67% to 35.17 ± 1.65%; p < 0.001), and monocytes increased (2.75 ± 0.44% to 4.35 ± 0.64%; p < 0.001). The human component was an uncontrolled, single-arm, pre–post study with no placebo, randomization, or blinding; hence, the results are hypothesis-generating. In CoCl2-treated H9c2 cells, the compounds improved metabolic activity and partially preserved bioenergetics. The uncontrolled human trial suggests β-glucan supplementation improves aerobic performance and alters hematological indices, though randomized controlled trials are needed to confirm these preliminary findings.